A 52-year-old man with chronic kidney disease (eGFR 25 mL/min/1.73m²) is started on a new drug. The clinician suspects altered drug clearance due to renal impairment. Which investigation is most appropriate to assess the pharmacokinetic profile and guide dosing adjustments?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.